跳至主要内容
临床试验/NCT00796809
NCT00796809已完成不适用

Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis

University of Arizona1 个研究点 分布在 1 个国家目标入组 598 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
598
试验地点
1
主要终点
Determine the incidence rate and calculate the risk of coccidioidomycosis in patients receiving various anti-TNF agents or other biologics, and patients not receiving these agents for their inflammatory arthritis

研究概览

简要总结

The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.

详细描述

Retrospective chart review of all patients with an inflammatory arthritis seen at the University Rheumatology clinic since January 2000.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All active patients with an inflammatory arthritis seen at the University of Arizona from January 2000

排除标准

  • 未提供

结局指标

主要结局

Determine the incidence rate and calculate the risk of coccidioidomycosis in patients receiving various anti-TNF agents or other biologics, and patients not receiving these agents for their inflammatory arthritis

时间窗: one year

次要结局

  • To compare number of disseminated cases of coccidioidomycosis in each group(One year)
  • To calculate the incidence density of coccidioidomycosis cases in patients receiving each drug.(One year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验